{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:21Z","timestamp":1793407581594,"version":"4.5.0"},"reference-count":63,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0378-6323.183635","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T10:45:05Z","timestamp":1465296305000},"page":"478","source":"Crossref","is-referenced-by-count":88,"title":["Livedoid vasculopathy: A review of pathogenesis and principles of management"],"prefix":"10.25259","volume":"82","author":[{"given":"Biju","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Neema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.183635-1","first-page":"31","volume-title":"Livedo reticularis with summer ulcerations","author":"Feldaker","year":"1955","journal-title":"AMA Arch Derm"},{"key":"key-10.4103\/0378-6323.183635-2","first-page":"489","volume-title":"Livedo vasculitis.Segmental hyalinizing vasculitis of the dermis","author":"Bard","year":"1967","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-3","first-page":"215","volume-title":"Livedo vasculitis","author":"Fritsch","year":"1995","journal-title":"Hautarzt"},{"key":"key-10.4103\/0378-6323.183635-4","first-page":"151","volume-title":"Idiopathic atrophie blanche","author":"Amato","year":"2006","journal-title":"Skinmed"},{"key":"key-10.4103\/0378-6323.183635-5","first-page":"923","volume-title":"Tissue plasminogen activator for treatment of livedoid vasculitis","author":"Klein","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0378-6323.183635-6","first-page":"791","volume-title":"Livedoid vasculopathy \u2013 A vasculitic mimic","author":"Shankar","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.183635-7","first-page":"279","volume-title":"Homocysteinemia and livedoid vasculitis","author":"Gibson","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-8","first-page":"159","volume-title":"Livedoid vasculopathy.The role of hyperhomocysteinemia and its simple therapeutic consequences","author":"Meiss","year":"2006","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-9","first-page":"410","volume-title":"Livedoid vasculopathy in a patient with factor V mutation (Leiden)","author":"Biedermann","year":"2000","journal-title":"J Cutan Pathol"},{"key":"key-10.4103\/0378-6323.183635-10","first-page":"121","volume-title":"A case of livedoid vasculopathy associated with factor V Leiden mutation: Successful treatment with oral warfarin","author":"Kavala","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"key-10.4103\/0378-6323.183635-11","first-page":"1413","volume-title":"Livedoid vasculopathy: Further evidence for procoagulant pathogenesis","author":"Hairston","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-12","first-page":"129","volume-title":"Factor V Leiden and its relevance in patients with recurrent abortions","author":"Pauer","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/0378-6323.183635-13","first-page":"356","volume-title":"The prothrombin gene variant 20210A in venous and arterial thromboembolism","author":"Vicente","year":"1999","journal-title":"Haematologica"},{"key":"key-10.4103\/0378-6323.183635-14","first-page":"120","volume-title":"Heterozygous prothrombin gene mutation associated with livedoid vasculopathy","author":"Anavekar","year":"2007","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-15","first-page":"1081","volume-title":"Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis","author":"Gotlib","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-16","first-page":"840","volume-title":"Livedoid vasculopathy associated with heterozygous protein C deficiency","author":"Boyvat","year":"2000","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-17","first-page":"1410","volume-title":"Livedo vasculitis with protein C system deficiency","author":"Baccard","year":"1992","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-18","first-page":"1466","volume-title":"Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G\/4G) treated successfully with tissue plasminogen activator","author":"Deng","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-19","first-page":"447","volume-title":"Livedo vasculopathy vs small vessel cutaneous vasculitis: Cytokine and platelet P-selectin studies","author":"Papi","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-20","first-page":"1340","volume-title":"Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs \u2013 A prospective study","author":"Di","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.183635-21","first-page":"1982","volume-title":"Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant","author":"Atsumi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.183635-22","first-page":"1507","volume-title":"High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa","author":"Kawakami","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key-10.4103\/0378-6323.183635-23","first-page":"237","volume-title":"Atrophie blanche.A clinicopathological study of 27 patients","author":"Yang","year":"1991","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"key-10.4103\/0378-6323.183635-24","first-page":"422","volume-title":"The effect of aspirin on haemostatic activity in the treatment of chronic venous leg ulceration","author":"Ibbotson","year":"1995","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-25","first-page":"344","volume-title":"Livedoid vasculopathy associated with sickle cell trait: Significant improvement on aspirin treatment","author":"El","year":"2012","journal-title":"Int Wound J"},{"key":"key-10.4103\/0378-6323.183635-26","first-page":"684","volume-title":"Livedo vasculitis.Therapy with pentoxifylline","author":"Sams","year":"1988","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-27","first-page":"380","volume-title":"Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche","author":"Sauer","year":"1986","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-28","first-page":"448","volume-title":"Therapy of livedo vasculitis with pentoxifylline","author":"Ely","year":"1988","journal-title":"Cutis"},{"key":"key-10.4103\/0378-6323.183635-29","first-page":"263","volume-title":"Livedo vasculitis","author":"Zecevic","year":"2001","journal-title":"Vojnosanit Pregl"},{"key":"key-10.4103\/0378-6323.183635-30","first-page":"359","volume-title":"Antiplatelet therapy in atrophie blanche and livedo vasculitis","author":"Drucker","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-31","first-page":"91","volume-title":"Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G\/4G) and prothrombin G20210A heterozygosity: Response to t-PA therapy","author":"Antunes","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.183635-32","first-page":"23","volume-title":"Minidose heparin therapy for vasculitis of atrophie blanche","author":"Jetton","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-33","first-page":"231","volume-title":"Low-molecular-weight heparin in leg ulcers due to microangiopathy Results with curative doses in nineteen patients","author":"Guinier","year":"1996","journal-title":"Semaine Des Hopitaux"},{"key":"key-10.4103\/0378-6323.183635-34","doi-asserted-by":"crossref","unstructured":"Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: Report of 2 cases. Arch Dermatol 2003;139:987-90.","DOI":"10.1001\/archderm.139.8.987"},{"key":"key-10.4103\/0378-6323.183635-35","first-page":"898","volume-title":"Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy","author":"Kerk","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-36","first-page":"75","volume-title":"Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia","author":"Browning","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-37","first-page":"512","volume-title":"Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin","author":"Davis","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-38","first-page":"1011","volume-title":"Difficult management of livedoid vasculopathy","author":"Franc\u00e8s","year":"2004","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-39","first-page":"59","volume-title":"Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy","author":"Agirbasli","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"key-10.4103\/0378-6323.183635-40","first-page":"351","volume-title":"Fibrinolysis induced by danazol","author":"Rizzo","year":"1986","journal-title":"Blut"},{"key":"key-10.4103\/0378-6323.183635-41","first-page":"233","volume-title":"Danazol therapy in hypoplasminogenemia","author":"Shigekiyo","year":"1992","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0378-6323.183635-42","first-page":"749","volume-title":"Livedoid vasculitis.Response to low-dose danazol","author":"Hsiao","year":"1996","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.183635-43","first-page":"251","volume-title":"Low-dose danazol in the treatment of livedoid vasculitis","author":"Hsiao","year":"1997","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.183635-44","first-page":"935","volume-title":"Livedoid vasculitis with anticardiolipin antibodies: Improvement with danazol","author":"Wakelin","year":"1998","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-45","first-page":"22","volume-title":"Livedoid thrombotic vasculopathy responding to doxycycline therapy","author":"Keller","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/0378-6323.183635-46","first-page":"400","volume-title":"A ten-year retrospective study on livedo vasculopathy in Asian patients","author":"Gan","year":"2012","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.4103\/0378-6323.183635-47","doi-asserted-by":"crossref","unstructured":"Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 1986;14 (5 Pt 1):851-4","DOI":"10.1016\/S0190-9622(86)80551-5"},{"key":"key-10.4103\/0378-6323.183635-48","first-page":"637","volume-title":"Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: Results from a crossover trial","author":"Anderson","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"key-10.4103\/0378-6323.183635-49","first-page":"835","volume-title":"Clinical profile and treatment outcome of livedoid vasculitis: A case series","author":"Lee","year":"2003","journal-title":"Ann Acad Med Singapore"},{"key":"key-10.4103\/0378-6323.183635-50","first-page":"457","volume-title":"Widespread livedoid vasculopathy","author":"Marzano","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.183635-51","first-page":"166","volume-title":"Response of livedoid vasculitis to intravenous immunoglobulin","author":"Ravat","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-52","first-page":"796","volume-title":"Normal human polyspecific immunoglobulin G (intravenous immunoglobulin) modulates endothelial cell function in vitro","author":"Oravec","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0378-6323.183635-53","first-page":"404","volume-title":"Use of intravenous immunoglobulin in livedo vasculitis","author":"Amital","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"key-10.4103\/0378-6323.183635-54","first-page":"574","volume-title":"Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: An open trial evaluating 9 consecutive patients","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-55","first-page":"323","volume-title":"Hyperbaric medicine","author":"Fernandes","year":"2009","journal-title":"Acta Med Port"},{"key":"key-10.4103\/0378-6323.183635-56","first-page":"647","volume-title":"Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen","author":"Yang","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-57","first-page":"251","volume-title":"Livedoid vasculopathy: Long-term follow-up results following hyperbaric oxygen therapy","author":"Juan","year":"2006","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-58","first-page":"204","volume-title":"Livedo reticularis and livedoid vasculitis responding to PUVA therapy","author":"Choi","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.183635-59","first-page":"153","volume-title":"Livedoid vasculitis responding to PUVA therapy","author":"Lee","year":"2001","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-60","first-page":"154","volume-title":"Refractory livedoid vasculitis responding to PUVA: A report of four cases","author":"Tuchinda","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"key-10.4103\/0378-6323.183635-61","first-page":"101","volume-title":"Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin","author":"Rustin","year":"1989","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.183635-62","first-page":"1055","volume-title":"Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy","author":"Zeni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key-10.4103\/0378-6323.183635-63","first-page":"1886","volume-title":"Smoking and abdominal obesity: Risk factors for venous thromboembolism among middle-aged men: \u201cThe study of men born in 1913\u201d","author":"Hansson","year":"1999","journal-title":"Arch Intern Med"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:45:25Z","timestamp":1611917125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/livedoid-vasculopathy-a-review-of-pathogenesis-and-principles-of-management\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"alternative-id":["183635"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.183635","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}